Lorem Ipsum
Lorem Ipsum

Lorem Ipsum

Lorem Ipsum

Zur Rose Group
06/04/2022
Ad hoc News

Zur Rose Group AG publishes invitation to the Annual General Meeting of 28 April 2022

Read more
Max Müller to
28/03/2022
Corporate News

Max Müller to be new CEO of TeleClinic, taking over from founder and former CEO Katharina Jünger

Read more
Zur Rose Group:
24/03/2022
Ad hoc News

Zur Rose Group: Excellent starting position for e-prescriptions set up and ecosystem strategy successfully continued

Read more
Zur Rose Group:
20/01/2022
Corporate News

Zur Rose Group: steady growth in a volatile market environment

Read more
Zur Rose Group
10/01/2022
Corporate News

Zur Rose Group nominates Rongrong Hu as director

Read more
Zur Rose and
16/12/2021
Corporate News

Zur Rose and the Swiss Association for the Blind and Visually Impaired make it easier for people with a visual impairment to take medication

Read more
Zur Rose Group
09/12/2021
Ad hoc News

Zur Rose Group successfully completed capital increase from authorised capital and sets placement price at CHF 290 per new share

Read more
Zur Rose Group
08/12/2021
Ad hoc News

Zur Rose Group decides on capital increase from authorised capital and starts accelerated bookbuilding to make full use of increasing market opportunities

Read more
eHealth-Tec achieves first
26/11/2021
Corporate News

eHealth-Tec achieves first place in the TOP 100 competition

Read more
Roche and the
28/10/2021
Corporate News

Roche and the Zur Rose Group announce collaboration to offer innovative health journeys for people living with diabetes

Read more
Zur Rose Group:
21/10/2021
Ad hoc News

Zur Rose Group: Board of Directors nominates Walter Oberhänsli as Chairman and appoints Walter Hess as new CEO

Read more
Zur Rose Group
21/10/2021
Ad hoc News

Zur Rose Group continues to grow strongly

Read more
Health app Well
24/08/2021
Corporate News

Health app Well heralds the future of healthcare

Read more
Zur Rose Group
18/08/2021
Ad hoc News

Zur Rose Group accelerates growth in second quarter with revenue up 26 per cent

Read more
No more paper:
09/07/2021
Corporate News

No more paper: e-prescriptions are coming

Read more
Zur Rose Group
15/06/2021
Corporate News

Zur Rose Group strengthens Group Management: Madhu Nutakki to become Chief Technology Officer

Read more
Faster and more
28/05/2021
Corporate News

Faster and more secure access to the gematik e-prescription with eHealth-Tec: Compatible software development kit for software providers

Read more
Annual General Meeting
29/04/2021
Corporate News

Annual General Meeting of Zur Rose Group AG: Shareholders approve all proposals

Read more
DocMorris expands management
29/04/2021
Corporate News

DocMorris expands management team: Dr. Ulrich Thomé is appointed Chief Strategy Officer

Read more
Zur Rose Group
20/04/2021
Corporate News

Zur Rose Group signals dynamic revenue development in the first quarter of 2021

Read more
Zur Rose Group
07/04/2021
Corporate News

Zur Rose Group AG publishes invitation to the Annual General Meeting on 29 April 2021

Read more
Introducing DocMorris Adipositas
31/03/2021
Corporate News

Introducing DocMorris Adipositas Care (Obesity Care), a digital hub empowering people with obesity to find relevant care for a better quality of life.

Read more
Zur Rose Group
18/03/2021
Corporate News

Zur Rose Group further extends European market leadership and successfully implements healthcare platform

Read more
DocMorris goes European:
11/02/2021
Corporate News

DocMorris goes European: new branding for marketplaces in Spain and France

Read more
The Zur Rose
21/01/2021
Corporate News

The Zur Rose Group accelerates growth

Read more
Zur Rose vindicated
13/01/2021
Corporate News

Zur Rose vindicated after court finds CEO Walter Oberhänsli not guilty

Read more
Collaboration between Zur
11/01/2021
Corporate News

Collaboration between Zur Rose Group and Novo Nordisk: The Zur Rose Group and Novo Nordisk combine their expertise to improve the health journeys of people with obesity

Read more
TeleClinic builds on
08/01/2021
Corporate News

TeleClinic builds on market leadership in telemedicine

Read more
The healthcare platform
18/12/2020
Corporate News

The healthcare platform of the future: DocMorris+ is launched

Read more
Local Pharmacy Strengthening
14/12/2020
Corporate News

Local Pharmacy Strengthening Act circumvents ECJ ruling

Read more
Ad hoc News06/04/2022

Zur Rose Group AG publishes invitation to the Annual General Meeting of 28 April 2022

Corporate News28/03/2022

Max Müller to be new CEO of TeleClinic, taking over from founder and former CEO Katharina Jünger

Ad hoc News24/03/2022

Zur Rose Group: Excellent starting position for e-prescriptions set up and ecosystem strategy successfully continued

Corporate News20/01/2022

Zur Rose Group: steady growth in a volatile market environment

Corporate News10/01/2022

Zur Rose Group nominates Rongrong Hu as director

Corporate News16/12/2021

Zur Rose and the Swiss Association for the Blind and Visually Impaired make it easier for people with a visual impairment to take medication

Ad hoc News09/12/2021

Zur Rose Group successfully completed capital increase from authorised capital and sets placement price at CHF 290 per new share

Ad hoc News08/12/2021

Zur Rose Group decides on capital increase from authorised capital and starts accelerated bookbuilding to make full use of increasing market opportunities

Corporate News26/11/2021

eHealth-Tec achieves first place in the TOP 100 competition

Corporate News28/10/2021

Roche and the Zur Rose Group announce collaboration to offer innovative health journeys for people living with diabetes

Ad hoc News21/10/2021

Zur Rose Group: Board of Directors nominates Walter Oberhänsli as Chairman and appoints Walter Hess as new CEO

Ad hoc News21/10/2021

Zur Rose Group continues to grow strongly

Corporate News24/08/2021

Health app Well heralds the future of healthcare

Ad hoc News18/08/2021

Zur Rose Group accelerates growth in second quarter with revenue up 26 per cent

Corporate News09/07/2021

No more paper: e-prescriptions are coming

Corporate News15/06/2021

Zur Rose Group strengthens Group Management: Madhu Nutakki to become Chief Technology Officer

Corporate News28/05/2021

Faster and more secure access to the gematik e-prescription with eHealth-Tec: Compatible software development kit for software providers

Corporate News29/04/2021

Annual General Meeting of Zur Rose Group AG: Shareholders approve all proposals

Corporate News29/04/2021

DocMorris expands management team: Dr. Ulrich Thomé is appointed Chief Strategy Officer

Corporate News20/04/2021

Zur Rose Group signals dynamic revenue development in the first quarter of 2021

Corporate News07/04/2021

Zur Rose Group AG publishes invitation to the Annual General Meeting on 29 April 2021

Corporate News31/03/2021

Introducing DocMorris Adipositas Care (Obesity Care), a digital hub empowering people with obesity to find relevant care for a better quality of life.

Corporate News18/03/2021

Zur Rose Group further extends European market leadership and successfully implements healthcare platform

Corporate News11/02/2021

DocMorris goes European: new branding for marketplaces in Spain and France

Corporate News21/01/2021

The Zur Rose Group accelerates growth

Corporate News13/01/2021

Zur Rose vindicated after court finds CEO Walter Oberhänsli not guilty

Corporate News11/01/2021

Collaboration between Zur Rose Group and Novo Nordisk: The Zur Rose Group and Novo Nordisk combine their expertise to improve the health journeys of people with obesity

Corporate News08/01/2021

TeleClinic builds on market leadership in telemedicine

Corporate News18/12/2020

The healthcare platform of the future: DocMorris+ is launched

Corporate News14/12/2020

Local Pharmacy Strengthening Act circumvents ECJ ruling

Corporate News10/12/2020

Zur Rose Group AG: Olaf Heinrich, Head Germany, is leaving the Zur Rose Group; his successor will be Walter Hess, Head Switzerland

Corporate News26/11/2020

New branding for a new vision: DocMorris

Corporate News16/11/2020

Zur Rose Group: gematik awards tender for specialist e-prescription service - Zur Rose subsidiary eHealth-Tec involved as partner to IBM

Corporate News13/11/2020

Allianz Care, CSS, Visana and Zur Rose Group in ground-breaking digital healthcare platform partnership

Corporate News21/10/2020

Zur Rose Group accelerates growth in third quarter 2020

Corporate News08/09/2020

Zur Rose and KPT together launch digital medicines assistant Medi+

Corporate News19/08/2020

Zur Rose Group reinforces European market leadership by rigorously implementing the growth and platform strategy

Corporate News17/08/2020

Zur Rose Group successfully concluded acquisition of the e-commerce and diabetes activities of Apotal Group

Corporate News31/07/2020

Zur Rose Group successfully concluded acquisition of TeleClinic

Corporate News17/07/2020

Zur Rose Group successfully completed capital increase from authorized capital and sets placement price

Corporate News16/07/2020

Zur Rose Group AG resolves on capital increase from authorized Capital

Corporate News16/07/2020

Zur Rose Group gives indications for half-year results

Corporate News16/07/2020

Zur Rose Group acquires TeleClinic, Germany's leading telemedicine provider

Corporate News26/06/2020

Zur Rose Group strengthens European market leadership through acquisition of mail-order and diabetes activities of Apotal Group

Corporate News03/05/2020

Zur Rose Group: Charges in connection with mail-order of non-prescription drugs and electronic prescribing

Corporate News23/04/2020

2020 Annual General Meeting of Zur Rose Group AG: Shareholders adopt all proposals

Corporate News20/04/2020

Zur Rose Group AG publishes adjusted proposal for the creation of authorized share capital and withdraws the agenda item relating to the creation of additional conditional capital for the Annual General Meeting 2020

Corporate News16/04/2020

Zur Rose Group starts 2020 with strong growth

Corporate News02/04/2020

Zur Rose Group AG publishes invitation to the Annual General Meeting on 23 April 2020

Corporate News26/03/2020

Zur Rose Group AG successfully completes the placement of CHF 175 million Convertible Bonds due 2025

Corporate News26/03/2020

Zur Rose Group AG launches CHF 150 million Convertible Bonds due 2025 with up to CHF 25 million increase option

Corporate News23/03/2020

COVID-19: Zur Rose is calling for an exception allowing the mail-orders for over-the-counter emergency, cold and flu medicines

Corporate News19/03/2020

Zur Rose Group maintains growth momentum

Corporate News12/03/2020

Zur Rose Group broadens its leadership structure and completes Group Management

Corporate News22/01/2020

Zur Rose Group posts 30 per cent growth in 2019

Corporate News13/01/2020

Zur Rose Group strengthens Group Management: Bernd Gschaider becomes Chief Operations Officer

Corporate News27/12/2019

Zur Rose Group: Purchase price payment for medpex acquisition completed early by earn-out settlement

Corporate News20/12/2019

Cooperation between Medbase and Zur Rose: The two joint ventures between Zur Rose and Medbase will commence operations at the start of the year

Corporate News01/11/2019

Zur Rose Group AG increases public bond to CHF 200 million

Corporate News29/10/2019

Cooperation between Migros and Zur Rose: Zur Rose and Migros open the first shop-in-shop pharmacy in French-speaking Switzerland

Corporate News24/10/2019

Zur Rose Group AG successfully issues a public straight bond of CHF 180 million

Corporate News23/10/2019

Zur Rose Group posts acceleration of growth in third quarter 2019

Corporate News21/08/2019

Zur Rose Group grows almost 30 per cent in the first half of 2019

Corporate News05/06/2019

Cooperation between Migros Group and Zur Rose: Zur Rose and Migros step up cooperation

Corporate News23/05/2019

Zur Rose shareholders adopt all proposals

Corporate News30/04/2019

Zur Rose Group AG publishes invitation to the Annual General Meeting of Shareholders on 23 May 2019

Corporate News17/04/2019

Zur Rose Group grows 28 per cent in the first quarter of 2019

Corporate News15/04/2019

The Zur Rose Group nominates three new board members

Corporate News21/03/2019

The Zur Rose Group accelerates growth

Corporate News12/03/2019

Zur Rose Group accelerates internationalisation

Corporate News04/03/2019

Change on the Board of Directors of the Zur Rose Group

Corporate News23/01/2019

Zur Rose Group realised its expansion goals in 2018 and grew by over 20 percent

Corporate News07/01/2019

Zur Rose Group: Acquisition of medpex successfully concluded

Corporate News03/01/2019

Zur Rose Group increases share capital

Corporate News04/12/2018

Further information on the rights issue

Corporate News03/12/2018

Further information on the rights issue

Corporate News29/11/2018

Zur Rose Group successfully concludes rights issue and announces offer price of CHF 93 per new share

Corporate News28/11/2018

Zur Rose Group announces result of rights take-up

Corporate News19/11/2018

Shareholders of Zur Rose Group AG approve capital increase

Corporate News19/11/2018

Zur Rose Group announces the terms of the planned capital increase by way of a rights offering

Corporate News15/11/2018

Zur Rose Group increases its financial targets

Corporate News05/11/2018

The third Zur Rose shop-in-shop pharmacy opens at Migros headquarters in Zurich

Corporate News31/10/2018

Zur Rose Group AG: Takeover of apo-rot's mail-order activities successfully completed

Corporate News29/10/2018

Zur Rose Group proposes capital increase

Corporate News18/10/2018

Zur Rose Group takes over e-commerce activities of medpex, Germany's third-largest online pharmacy

Corporate News15/08/2018

Zur Rose Group records 30 percent sales growth in first half of 2018

Corporate News02/08/2018

Zur Rose Group AG: Acquisition of the Spanish marketplace platform Promofarma

Corporate News09/07/2018

Zur Rose Group AG increases public bond to CHF 115 million

Corporate News22/06/2018

Zur Rose Group AG successfully issues a public bond of CHF 85 million

Corporate News24/05/2018

2018 Annual General Meeting: Zur Rose shareholders adopt all proposals

Corporate News24/05/2018

Zur Rose Group AG: DocMorris and apo-rot cooperate

Corporate News18/04/2018

Marked surge in sales: Zur Rose Group grows 30 percent in the first quarter of 2018

Corporate News21/03/2018

Zur Rose Group implements successful growth strategy

Corporate News07/02/2018

Zur Rose Group AG: Statement on the draft coalition agreement in Germany: Rx mail-order ban not to be justified

Corporate News24/01/2018

Double-digit growth for the Zur Rose Group in 2017

Corporate News22/01/2018

Opening of more shop-in-shop pharmacies following successful launch

Corporate News29/12/2017

Zur Rose Group: Takeover of Eurapon and Vitalsana successfully concluded

Corporate News27/11/2017

Zur Rose Group focuses on healthcare services in Germany at its Halle location

Corporate News23/11/2017

Zur Rose-Group acquires mail-order pharmacy Vitalsana

Corporate News17/10/2017

Zur Rose Group speeds up its expansion programme, taking over Eurapon Pharmahandel GmbH

Corporate News29/09/2017

KPT and Zur Rose are launching an innovative model for basic insurance

Corporate News23/08/2017

Half-Year Results 2017: Zur Rose Group continues on growth trajectory

Corporate News12/07/2017

Zur Rose Group AG announces full exercise of Greenshoe

Corporate News11/07/2017

Strategic collaboration between Zur Rose and Medbase: Combination of medical and pharmaceutical competence and exclusive supply of drugs to Medbase Centres

Corporate News06/07/2017

Migros and Zur Rose: Opening of the first Zur Rose shop-in-shop pharmacy in a Migros branch

Corporate News05/07/2017

Zur Rose Group AG prices its IPO at CHF 140 per share and lists on SIX Swiss Exchange

Corporate News30/06/2017

Zur Rose Group AG announces narrowed price range and shortens the book-building period

Corporate News22/06/2017

Zur Rose Group AG launches IPO on SIX Swiss Exchange and sets price range

Corporate News19/06/2017

Extraordinary General Meeting of Zur Rose Group AG: Shareholders approve creation of authorised capital and revision to Articles of Association for initial public offering (IPO)

Corporate News08/06/2017

Zur Rose Group AG continues growth strategy and announces plans for listing on SIX Swiss Exchange

Corporate News30/05/2017

Zur Rose Group: Notice of an Extraordinary General Meeting to be held on 19 June 2017 and Setting the stage for raising additional funds to accelerate growth

Corporate News05/05/2017

Annual General Meeting of Zur Rose Group AG

No search results

Any questions?

Have a question? Want to know more?
Feel free to get in touch with us.

You can find specific contact information here

All contacts
Zur Rose Group AG

Walzmühlestrasse 60
8500 Frauenfeld
Switzerland